AJP - Lung Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (November 6, 2009). doi:10.1152/ajplung.00242.2009
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Osanai, K.
Right arrow Articles by Toga, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Osanai, K.
Right arrow Articles by Toga, H.
Submitted on July 23, 2009
Revised on October 15, 2009
Accepted on October 29, 2009

Altered lung surfactant system in a Rab38-deficient rat model of Hermansky-Pudlak syndrome

Kazuhiro Osanai1*, Junko Higuchi2, Rieko Oikawa1, Makoto Kobayashi1, Katsuma Tsuchihara1, Masaharu Iguchi1, Jyongsu Huang1, Dennis R. Voelker3, and Hirohisa Toga1

1 Kanazawa Medical University
2 Yamagata University Graduate School of Medicine
3 National Jewish Medical and Research Center

* To whom correspondence should be addressed. E-mail: k-osanai{at}kanazawa-med.ac.jp.

Several Long Evans rat substrains carrying the phenotype of oculocutaneous albinism and bleeding diathesis are a rat model of Hermansky-Pudlak syndrome (HPS). The mutation responsible for the phenotype (Ruby) was identified as a point mutation in the initiation codon of Rab38 small GTPase that regulates intracellular vesicle transport. As patients with HPS often develop life-limiting interstitial pneumonia accompanied with abnormal morphology of alveolar type II cells, we investigated lung surfactant system in Long Evans Cinnamon rats, one strain of the Ruby rats. The lungs showed conspicuous morphology of type II cells containing markedly enlarged lamellar bodies. Surfactant phosphatidylcholine and surfactant protein B were increased in lung tissues and lamellar bodies, but not in alveolar lumen. Expression levels of mRNA for surfactant protein A, B, C, and D were not altered. Isolated type II cells showed aberrant secretory pattern of newly synthesized [3H]phosphatidylcholine, i.e. decreased basal secretion and remarkably amplified agonist-induced secretion. [3H]phosphatidylcholine synthesis and uptake by type II cells were not altered. Thus, Rab38-deficient type II cells appear to carry abnormality in lung surfactant secretion but not in synthesis or uptake. These results suggest that aberrant lung surfactant secretion may be involved in the pathogenesis of interstitial pneumonia in HPS.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.